Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

ClinicalTrials.gov ID: NCT00450437

Public ClinicalTrials.gov record NCT00450437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 3:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center Study to Evaluate Lot to Lot Consistency, Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults and Compare to the Safety and Immune Response to a Licensed Conjugate Meningococcal ACWY Vaccine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the lot to lot consistency, safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine in healthy US adolescents and adults.

Study identification

NCT ID
NCT00450437
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Vaccines
Industry
Enrollment
3,539 participants

Conditions and interventions

Eligibility (public fields only)

Age range
11 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Aug 2007 (Actual)
Completion
Jan 2008 (Actual)
Last update posted
Jan 28, 2015

2007 – 2008

United States locations

U.S. sites
40
U.S. states
14
U.S. cities
40
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205, 35244 —
Not listed Tuscaloosa Alabama 35487 —
Not listed Fremont California 94538 —
Not listed Fresno California 93726 —
Not listed Hayward California 94545 —
Not listed Oakland California 94612 —
Not listed Roseville California 95661 —
Not listed Sacramento California 95817 —
Not listed San Jose California 95119 —
Not listed Denver Colorado 80218 —
Not listed Atlanta Georgia 30062 —
Not listed Marietta Georgia 30062 —
Not listed Woodstock Georgia 30189 —
Not listed Chicago Illinois 60614 —
Not listed Bardstown Kentucky 40004 —
Not listed Annapolis Maryland 21401 —
Not listed Baltimore Maryland 21201 —
Not listed Frederick Maryland 21702 —
Not listed Boston Massachusetts 02118 —
Not listed Fall River Massachusetts 02124 —
Not listed Lebanon New Hampshire 03756 —
Not listed Akron Ohio 44308 —
Not listed Cincinnati Ohio 45229 —
Not listed South Euclid Ohio 44121 —
Not listed Carnegie Pennsylvania 15106 —
Not listed Erie Pennsylvania 16505 —
Not listed Greenville Pennsylvania 16125 —
Not listed Grove City Pennsylvania 16127 —
Not listed Harleyville Pennsylvania 19438 —
Not listed Jefferson Borough Pennsylvania 15025 —
Not listed Latrobe Pennsylvania 15650 —
Not listed Pittsburgh Pennsylvania 15217 to 15241 —
Not listed Sellersville Pennsylvania 18960 —
Not listed Uniontown Pennsylvania 15401 —
Not listed Upper Saint Clair Pennsylvania 15241 —
Not listed Washington Pennsylvania 15301 —
Not listed Wexford Pennsylvania 15090 —
Not listed Galveston Texas 77555-0371 —
Not listed Salt Lake City Utah 84121 —
Not listed Seattle Washington 98101-1466 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00450437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2015 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00450437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →